Bibliography
- Shanafelt TD, Geyer SM, Kay NE. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004;103(4):1202-10
- Kay NE, O'Brien SM, Pettitt AR, et al. The role of prognostic factors in assessing ‘high-risk’ subgroups of patients with chronic lymphocytic leukemia. Leukemia 2007;21:1815-91
- Maontillo M, Hamblin T, Hallek, et al. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapy. Haematologica 2005;90(3):391-9
- Inamdar KV, Buseo-Ramos CE. Pathology of chronic lymphocytic leukemia: an update. Ann Diagn Pathol 2007;11:363-89
- Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-11
- Schwaenen C, Nessling M, Wessendorf S, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 2004;101:1039-44
- Tyybakinoja A, Vilpo J, Knuutila S. High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia. Cytogenet Genome Res 2007;118:8-12
- Pfeifer D, Pantic M, Skatulla I, et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 2007;109:1202-10
- Patel A, Kang SH, Lennon PA, et al. Validation of a targeted DNA microarray for clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia. Am J Hematol 2007; [Epub ahead of print]
- De Jong D, Van't Veer LJ. Tools for molecular risk-stratification for clinical purposes: CLL as a prototype. Eur J Hum Genet 2004;12:423
- Emanuel BS, Saittas SC. From microscopes to microarrays:dossectin recurrent chromosomal rearrangements. Nat Rev Genet 2007;8(11):869-83
- Kearny L, Horsley SW. Molecular cytogenetics in hematological malignancy: current technology and future prospects. Chromosoma 2005;114:286-94
- Ylstra B, van den Ijssel P, Carvalho B, et al. BAC to the future! Or oligonucleotides: a perspective for micro array comparative genomic hybridization. Nucleic Acids Res 2006;34:445-50
- Nowak N, Miecznikowski J, Moore SR, et al. Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genet Med 2007;9:585-95
- Fukuhara N, Nakamura T, Nakagawa M, et al. Chromosomal imbalances are associated with outcome of helicobacter pylori eradication in t(11;18)(q21;q21) negative gastric mucosa-associated lymphoid tissue lymphomas. Genes Chromosomes Cancer 2007;46:784-90
- Huntly BJ, Bench A, Green AR. Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia. Blood 2003;102:1160-8
- Reddy KS. Chronic lymphocytic leukemia profiled for prognosis using a fluorescence in situ hybridization panel. Br J Haematol 2006;132:705-22
- Sindelarova L, Michalova K, Zemanova Z, et al. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005;160:27-34
- Glassman AB, Hayes KJ. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005;158:88-91
- Gunn SR, Robetorye RS, Mohammed MS. Comparative genomic hybridization arrays in clinical pathology: progress and challenges. Mol Diagn Ther 2007;11(2):73-7
- Grever MR, Lucas DM, Johnson AJ, Byrd JC. Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007;20:545-56
- Krober A, Bloehdorn J, Hafner S, et al. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J Clin Oncol 2006;24(20):969-75
- Butler T, Gribben JG. Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukemia patients. Expert Opin Med Diagn 2008;2(1):101-12
- Stilgenbauer S, Sander S, Bullinger L, et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematology 2007;92(9):1242-5
- Shanafelt TD, Witzig TE, Fink SR, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with early-stage chronic lymphocytic leukemia. J Clin Oncol 2006;24(28):4634-41
- Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in CLL. N Engl J Med 2000;3:1910-6